破裂腹主动脉瘤修复术后死亡预测模型无法预测无效治疗且不适用于临床决策
该研究纳入2005至2014年一家大型大学医院收治的64例破裂腹主动脉瘤患者,评估7种评分算法预测死亡率的准确性。所有评分系统均高估死亡率10%至50%,系统间一致性差(κ 0.06-0.79),预测无效治疗(100%死亡率)的病例实际死亡率分别为60%和50%,表明这些算法不适用于临床决策。
要点
- 7种rAAA死亡预测评分均高估死亡率10%-50%,系统间一致性差。
- 预测为无效治疗的病例实际死亡率仅50%-60%,并非100%。
- 多数rAAA患者未被归入最高风险组,评分无法有效识别无效治疗。
核心结论
- 用于预测rAAA修复术后死亡率的临床算法不能有效预测无效治疗,对临床决策价值有限。
研究设计与样本
- 回顾性队列研究,纳入2005至2014年一家大型大学医院收治的64例rAAA患者。
主要发现
- 总体死亡率为30%(开放修复26%,腔内修复24%,未修复100%)。
- 各评分系统将5%至35%的患者归为高死亡风险组,系统间一致性差(κ 0.06-0.79)。
- 所有评分系统的实际死亡率(50%-70%)均低于预测死亡率(78%-100%),高估10%-50%。
- 未被归入高风险组的患者死亡率显著较低,为7%至29%。
- Hardman指数预测63例中5例无效治疗,其中1例未手术;University of Washington评分预测63例中2例无效治疗,其中1例未手术;这两例实际死亡率分别为60%和50%。
临床怎么用
- 不应仅依据现有评分算法决定是否对rAAA患者放弃手术干预。
局限性
- 样本量较小(64例),为单中心回顾性研究。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: The clinical decision-making utility of scoring algorithms for predicting mortality after ruptured abdominal aortic aneurysms (rAAAs) remains unknown. We sought to determine the clinical utility of the algorithms compared with our clinical decision making and outcomes for management of rAAA during a 10-year period. METHODS: Patients admitted with a diagnosis rAAA at a large university hospital were identified from 2005 to 2014. The Glasgow Aneurysm Score, Hardman Index, Vancouver Score, Edinburgh Ruptured Aneurysm Score, University of Washington Ruptured Aneurysm Score, Vascular Study Group of New England rAAA Risk Score, and the Artificial Neural Network Score were analyzed for accuracy in predicting mortality. Among patients quantified into the highest-risk group (predicted mortality >80%-85%), we compared the predicted with the actual outcome to determine how well these scores predicted futility. RESULTS: The cohort comprised 64 patients. Of those, 24 (38%) underwent open repair, 36 (56%) underwent endovascular repair, and 4 (6%) received only comfort care. Overall mortality was 30% (open repair, 26%; endovascular repair, 24%; no repair, 100%). As assessed by the scoring systems, 5% to 35% of patients were categorized as high-mortality risk. Intersystem agreement was poor, with κ values ranging from 0.06 to 0.79. Actual mortality was lower than the predicted mortality (50%-70% vs 78%-100%) for all scoring systems, with each scoring system overestimating mortality by 10% to 50%. Mortality rates for patients not designated into the high-risk cohort were dramatically lower, ranging from 7% to 29%. Futility, defined as 100% mortality, was predicted in five of 63 patients with the Hardman Index and in two of 63 of the University of Washington score. Of these, surgery was not offered to one of five and one of two patients, respectively. If one of these two models were used to withhold operative intervention, the mortality of these patients would have been 100%. The actual mortality for these patients was 60% and 50%, respectively. CONCLUSIONS: Clinical algorithms for predicting mortality after rAAA were not useful for predicting futility. Most patients with rAAA were not classified in the highest-risk group by the clinical decision models. Among patients identified as highest risk, predicted mortality was overestimated compared with actual mortality. The data from this study support the limited value to surgeons of the currently published algorithms.
引用
- Thompson PC, Dalman RL, Harris EJ, et al. Predictive models for mortality after ruptured aortic aneurysm repair do not predict futility and are not useful for clinical decision making. J Vasc Surg. 2016. PMID: 27871490. doi:10.1016/j.jvs.2016.07.121
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。